-
Subject Areas on Research
-
"Dedifferentiated" chordoma: a case report of the cytomorphologic findings on fine-needle aspiration.
-
"Tips" on acute arthritis and clubbing.
-
211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation.
-
4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial.
-
5-Fluorouracil in childhood solid tumors.
-
64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer.
-
A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603).
-
A Novel Staging System for De Novo Metastatic Breast Cancer Refines Prognostic Estimates.
-
A case of curative-intent hepatectomy for colon cancer metastatic to the scapula and liver.
-
A multiphase immunotherapy regimen for human melanoma: clinical and laboratory results.
-
A mutant PTH/PTHrP type I receptor in enchondromatosis.
-
A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.
-
A novel, non-apoptotic role for Scythe/BAT3: a functional switch between the pro- and anti-proliferative roles of p21 during the cell cycle.
-
A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer.
-
A phase II Hoosier Oncology Group study of vinorelbine and estramustine phosphate in hormone-refractory prostate cancer.
-
A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancer.
-
A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events.
-
A quantitative microscopic approach to predict local recurrence based on in vivo intraoperative imaging of sarcoma tumor margins.
-
A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy.
-
A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer.
-
ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling.
-
ACR Appropriateness Criteria® Primary Bone Tumors.
-
ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging.
-
ACR-ACNM-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With Radium-223.
-
Aberrant expression of tumor suppressor proteins in the Ewing family of tumors.
-
Acquisition of metastatic tissue from patients with bone metastases from breast cancer.
-
Activating mutations of Gs protein in monostotic fibrous lesions of bone.
-
Acute pancreatitis associated with administration of a nitric oxide synthase inhibitor in tumor-bearing dogs.
-
Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection.
-
Adjuvant chemotherapy for osteosarcoma of the extremity. Long-term results of two consecutive prospective protocol studies.
-
Adjuvant chemotherapy in nonmetastatic osteosarcoma: a Southwest Oncology Group Study.
-
Aggressive (epithelioid) osteoblastoma arising in soft tissue.
-
Allografts about the Knee in Young Patients with High-Grade Sarcoma.
-
An evolutionary framework for treating pediatric sarcomas.
-
Anterior chest wall mass in an elderly male.
-
Arterial spin labeling blood flow magnetic resonance imaging for the characterization of metastatic renal cell carcinoma(1).
-
Assessment of anatomic extent and biologic hazard of prostatic adenocarcinoma.
-
Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC).
-
Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials.
-
Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel.
-
Association between ratio of matrix metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma.
-
Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma.
-
Autopsy and grief: a case of transformative postmortem examination.
-
BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
-
Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin.
-
Beyond Mirels: Factors Influencing Surgical Outcome of Metastasis to the Extremities in the Modern Era.
-
Biomarkers in the management and treatment of men with metastatic castration-resistant prostate cancer.
-
Bone Morphogenetic Proteins Are Expressed by Both Bone-Forming and Non-Bone-Forming Lesions.
-
Bone and soft tissue lesions: diagnosis with combined H-1 MR imaging and P-31 MR spectroscopy.
-
Bone cancer clinical practice guidelines.
-
Bone cancer.
-
Bone cancer.
-
Bone cancer.
-
Bone metastases from breast cancer: value of CT bone windows.
-
Bone scan positivity in non-metastatic, castrate-resistant prostate cancer: external validation study.
-
CT-Guided Bone Biopsies in Metastatic Castration-Resistant Prostate Cancer: Factors Predictive of Maximum Tumor Yield.
-
CYP3A4/5 and pharmacogenetics in patients with sarcoma - Authors' reply.
-
Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial.
-
Cancer-related fatigue.
-
Capromab Pendetide imaging of prostate cancer.
-
Cartilage tumours and bone development: molecular pathology and possible therapeutic targets.
-
Cavernous hemangioma of the skull presenting with subdural hematoma. Case report.
-
Childhood cancer and occupational radiation exposure in parents.
-
Chondrosarcoma of bone: analysis of 108 cases and evaluation for predictors of outcome.
-
Choosing wisely: the American Society for Radiation Oncology's top 5 list.
-
Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide.
-
Clinical reasoning and advanced practice privileges enable physical therapist point-of-care decisions in the military health care system: 3 clinical cases.
-
Collagenase specificity in chondrosarcoma metastasis.
-
Combination chemotherapy for osteosarcoma.
-
Combination short-course preoperative irradiation, surgical resection, and reduced-field high-dose postoperative irradiation in the treatment of tumors involving the bone.
-
Common genetic variants associated with telomere length confer risk for neuroblastoma and other childhood cancers.
-
Comparison of two long-term chemotherapy regimens, with or without agents to modify skeletal repair, in multiple myeloma.
-
Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer.
-
Computed tomography of the hindfoot.
-
Concordance of histopathologic and cytologic grading in musculoskeletal sarcomas: can grades obtained from analysis of the fine-needle aspirates serve as the basis for therapeutic decisions?
-
Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer.
-
Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation.
-
Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer.
-
Counterpoints: Which should be used first in symptomatic metastatic castration-resistant prostate cancer, docetaxel or radium? Radium-223 is the preferred therapy in bone-predominant symptomatic metastatic castration-resistant prostate cancer.
-
Current concepts. Cancer in children.
-
Cytopathology of mesenchymal chondrosarcomas: a report and comparison of four patients.
-
Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma.
-
Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study.
-
Dedifferentiated parosteal osteosarcoma with giant cell tumor component.
-
Delayed activation of spinal microglia contributes to the maintenance of bone cancer pain in female Wistar rats via P2X7 receptor and IL-18.
-
Deletions and point mutations of p16,p15 gene in primary tumors and tumor cell lines.
-
Desmoplastic fibroma.
-
Development of a method to isolate circulating tumor cells using mesenchymal-based capture.
-
Developmental pathways in musculoskeletal neoplasia: involvement of the Indian Hedgehog-parathyroid hormone-related protein pathway.
-
Differential gene expression profiling of aggressive and nonaggressive follicular carcinomas.
-
Disruption of crosstalk between mesenchymal stromal and tumor cells in bone marrow as a therapeutic target to prevent metastatic bone disease.
-
Distinct Roles of Glutamine Metabolism in Benign and Malignant Cartilage Tumors With IDH Mutations.
-
Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?
-
EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1.
-
EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma.
-
Early follow-up of a custom non-fluted diaphyseal press-fit tumour prosthesis.
-
Economic evaluation of zoledronic acid versus pamidronate for the prevention of skeletal-related events in metastatic breast cancer and multiple myeloma.
-
Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer.
-
Effective salvage therapy for refractory disseminated breast cancer with 5-fluorouracil and high-dose continuous infusion folinic acid.
-
Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer.
-
Efficacy and Effect of Cabozantinib on Bone Metastases in Treatment-naive Castration-resistant Prostate Cancer.
-
Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses.
-
Electrophoretic evaluation of sera from dogs with cancer.
-
Enchondromatosis and Growth Plate Development.
-
Epidermal growth factor receptor signaling promotes metastatic prostate cancer through microRNA-96-mediated downregulation of the tumor suppressor ETV6.
-
Epithelioid and epithelial neoplasms of bone.
-
Estrogen receptor determination in percutaneous bone marrow biopsies of patients with metastatic breast cancer.
-
Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials.
-
Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer.
-
Evaluation of the paracrine and endocrine effects of genitourinary tumor produced growth factors.
-
Ewing's sarcoma of the hand.
-
Ewing's sarcoma.
-
Exploratory analysis of Fas gene polymorphisms in pediatric osteosarcoma patients.
-
Expression of osteocalcin and its transcriptional regulators core-binding factor alpha 1 and MSX2 in osteoid-forming tumours.
-
FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
-
Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer.
-
Favorable response to nivolumab in a young adult patient with metastatic histiocytic sarcoma.
-
Fibular osteochondroma presenting as chronic ankle sprain.
-
Fine needle aspiration of osteogenic sarcoma metastatic to the lung. A report of four cases.
-
Fine-needle aspiration diagnosis of medulloblastoma metastatic to the pelvis.
-
Following the forgotten phosphorus.
-
Free vascularized fibula in traumatic long bone defects and in limb salvaging following tumor resection: comparative study.
-
Free vascularized fibular graft reconstruction of large skeletal defects after tumor resection.
-
Free vascularized fibular grafts for reconstruction of skeletal defects.
-
Functional screen identifies kinases driving prostate cancer visceral and bone metastasis.
-
Genetic determinants of childhood and adult height associated with osteosarcoma risk.
-
Giant cell tumor of rib masquerading as thymoma: a diagnostic pitfall in needle core biopsy of the mediastinum.
-
Giant-cell tumor of the appendicular skeleton.
-
Gli2 and p53 cooperate to regulate IGFBP-3- mediated chondrocyte apoptosis in the progression from benign to malignant cartilage tumors.
-
Global reluctance to practice evidence-based medicine continues in the treatment of uncomplicated painful bone metastases despite level 1 evidence and practice guidelines.
-
Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions.
-
Hodgkin's lymphoma of the breast.
-
Hospice Admission and Survival After 18
F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry.
-
Hyperlucent lung after radiation therapy.
-
Iatrogenic lesions of soft tissue and bone.
-
Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate.
-
Identifying Modifiable and Non-modifiable Risk Factors of Readmission and Short-Term Mortality in Osteosarcoma: A National Cancer Database Study.
-
Image guidance in osteoplasty and fixation.
-
Imaging appearances of the sternum and sternoclavicular joints.
-
Imaging of primary Ewing sarcoma with 13N-L-glutamate.
-
Imaging of primary multifocal osseous lymphoma.
-
Immune dysregulation and osteosarcoma: Staphylococcus aureus downregulates TGF-β and heightens the inflammatory signature in human and canine macrophages suppressed by osteosarcoma.
-
Immunotherapy for osteosarcoma: Where do we go from here?
-
In situ mass spectrometry imaging reveals heterogeneous glycogen stores in human normal and cancerous tissues.
-
Incidence of anemia in children with solid tumors or Hodgkin disease.
-
Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma.
-
Influence of trauma on the unusual distribution of metastases from carcinoma of the larynx.
-
Inhibition of notch signaling induces neural differentiation in Ewing sarcoma.
-
Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673.
-
Integrating carthage-specific T1rho MRI into knee clinic diagnostic imaging.
-
Intended Versus Inferred Treatment After 18F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry.
-
Internally administered isotopes in the treatment of solid malignancy.
-
Intra-arterial cisplatin with or without radiation in limb-sparing for canine osteosarcoma.
-
Intra-arterial cisplatinum in preparation for the limb salvage procedure.
-
Intracranial metastatic adenocarcinoma of the prostate presenting as visual disturbance.
-
Intrathoracic metastasis from an extrathoracic malignancy: a radiographic approach to patient evaluation.
-
Invasiveness is associated with metastasis and decreased survival in hemangiopericytoma of the central nervous system.
-
Investigating readmission rates for patients undergoing oncologic resection and endoprosthetic reconstruction for primary sarcomas and tumors involving bone.
-
Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma.
-
Ipsilateral fibular slide grafts in the management of distal fibula lesions.
-
Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database.
-
Isolated musculocutaneous neuropathy caused by a proximal humeral exostosis.
-
Ivory vertebra on 18F-sodium fluoride scan: an old sign in a new modality.
-
Jaffe-Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder.
-
Jaffe-Campanacci syndrome. A case report and review of the literature.
-
Lesions of bone and bladder cancer.
-
Limb salvage procedures in children with osteosarcoma.
-
Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy.
-
Local complications after limb-salvage surgery for pediatric bone tumours: a pictorial essay.
-
Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer.
-
Long-term survivors of childhood Ewing sarcoma: report from the childhood cancer survivor study.
-
Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer.
-
Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.
-
Loss of ATRX promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin binding.
-
Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.
-
Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer.
-
Loss of p16(INK4a) expression correlates with decreased survival in pediatric osteosarcomas.
-
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.
-
Management of pelvic sarcoma.
-
Managing the complications of plasma cell myeloma.
-
Marshall Urist Award. Interstitial collagenase gene expression correlates with in vitro invasion in human chondrosarcoma.
-
Massive allografts in the treatment of osteosarcoma and Ewing sarcoma in children and adolescents.
-
Mastoid osteoma: A case report and review of the literature.
-
Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials.
-
Mesenchymal Tumors Can Derive from Ng2/Cspg4-Expressing Pericytes with β-Catenin Modulating the Neoplastic Phenotype.
-
Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer.
-
Metacarpal reconstruction with free autogenous cartilage and bone following tumor resection. A case report.
-
Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors.
-
Metastatic squamous cell carcinoma with pseudoangiosarcomatous features and aberrant expression of vascular markers.
-
Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor/insulin receptor: potential therapeutic targets in chordoma.
-
Microsurgery in musculoskeletal oncology.
-
Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET.
-
Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience.
-
Multifocal vascular lesions of bone: imaging characteristics.
-
Multiple hereditary exostoses (MHE): elucidating the pathogenesis of a rare skeletal disorder through interdisciplinary research.
-
Multiple relapses of Clostridium difficile-associated diarrhea in a cancer patient. Successful control with long-term cholestyramine therapy.
-
Musculoskeletal case of the day. Giant cell tumor of the sacrum.
-
NCCN Guidelines Insights: Bone Cancer, Version 2.2017.
-
NFκB-mediated CXCL1 production in spinal cord astrocytes contributes to the maintenance of bone cancer pain in mice.
-
NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia.
-
National inpatient complications and outcomes after surgery for spinal metastasis from 1993-2002.
-
Neurosurgical management of petrous bone lesions: classification system and selection of surgical approaches.
-
New and emerging therapies for bone metastases in genitourinary cancers.
-
New secrets behind bone metastasis.
-
Noninvasive visualization of retinoblastoma growth and metastasis via bioluminescence imaging.
-
Objective evaluation of bone metastases in prostate cancer: to what end?
-
Oncogenic osteomalacia caused by phosphaturic mesenchymal tumor of the temporal bone.
-
Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases.
-
Opportunities for improving the therapeutic ratio for patients with sarcoma.
-
Optical coherence tomography of choroidal osteoma in 22 cases: evidence for photoreceptor atrophy over the decalcified portion of the tumor.
-
Optimal pediatric dosing of anti-platelet agents for pipeline stent embolization -a case report and review of the literature.
-
Optimal use of radium-223 in patients with metastatic castration-resistant prostate cancer.
-
Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial.
-
Osteoblastic metastases from astrocytomas: a report of two cases.
-
Osteochondroma of ventral scapula associated with chest pain due to rib cage compression: A case report.
-
Osteoid osteoma and osteoblastoma.
-
Osteoid osteoma of the clavicle.
-
Osteoid osteoma of the neck of the talus: percutaneous, computed tomography-guided technique for complete excision.
-
Osteoprotegerin in bone metastases: mathematical solution to the puzzle.
-
Osteosarcomatosis.
-
PD-1 blockade inhibits osteoclast formation and murine bone cancer pain.
-
PET imaging of osteosarcoma in dogs using a fluorine-18-labeled monoclonal antibody Fab fragment.
-
PET/Computed Tomography and Precision Medicine: Musculoskeletal Sarcoma.
-
PSA progression following radical prostatectomy and radiation therapy: new standards in the new Millennium.
-
Pain predicts overall survival in men with metastatic castration-refractory prostate cancer.
-
Pain, PSA flare, and bone scan response in a patient with metastatic castration-resistant prostate cancer treated with radium-223, a case report.
-
Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline.
-
Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline.
-
Palliative radiotherapy for prostate cancer.
-
Parathyroid hormone-related protein regulates glioma-associated oncogene transcriptional activation: lessons learned from bone development and cartilage neoplasia.
-
Patched-one or smoothened gene mutations are infrequent in chondrosarcoma.
-
Pathologic fractures through nonossifying fibromas: is prophylactic treatment warranted?
-
Pathological bone fractures in a 20-year old athletic male with multifocal solitary plasmacytoma of bone.
-
Patient preferences for treatments to delay bone metastases.
-
Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors.
-
Patterns of response and progression in bone and soft tissue during and after treatment with radium-223 for metastatic castrate-resistant prostate cancer.
-
Pediatric primary bone lymphoma-diffuse large B-cell lymphoma: morphologic and immunohistochemical characteristics of 10 cases.
-
Pediatric radiation oncology.
-
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
-
Perinatal factors associated with clinical presentation of osteosarcoma in children and adolescents.
-
Petrous bone lesions: surgical implementation and outcomes of extradural subtemporal approach.
-
Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer.
-
Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone.
-
Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98).
-
Phase II evaluation of oral estramustine, oral etoposide, and intravenous paclitaxel in patients with hormone-sensitive prostate adenocarcinoma.
-
Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinib.
-
Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial.
-
Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation.
-
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.
-
Physical activity among adult survivors of childhood lower-extremity sarcoma.
-
Physicians' preferences for bone metastases drug therapy in the United States.
-
Poland's syndrome and lymphoma.
-
Practice patterns and predictors of followup imaging after a negative bone scan in men with castration resistant prostate cancer: results from the SEARCH database.
-
Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma.
-
Predicting bone scan positivity after biochemical recurrence following radical prostatectomy in both hormone-naive men and patients receiving androgen-deprivation therapy: results from the SEARCH database.
-
Predicting bone scan positivity in non-metastatic castration-resistant prostate cancer.
-
Predictors of prostate cancer tissue acquisition by an undirected core bone marrow biopsy in metastatic castration-resistant prostate cancer--a Cancer and Leukemia Group B study.
-
Predictors of skeletal-related events and mortality in men with metastatic, castration-resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
-
Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measure.
-
Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal Center.
-
Primary carcinoma of the upper urinary tract. Effect of primary and secondary therapy on survival.
-
Primary chest wall tumors.
-
Primary chondroid melanoma.
-
Primary cilia attenuate hedgehog signalling in neoplastic chondrocytes.
-
Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate.
-
Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone- refractory prostate cancer: results from cancer and leukemia group B 150005/9480.
-
Prophylactic Antibiotic Regimens In Tumor Surgery (PARITY): a multi-center randomized controlled study comparing alternative antibiotic regimens in patients undergoing tumor resections with endoprosthetic replacements-a statistical analysis plan.
-
Prostate cancer, version 1.2014.
-
Prostate-specific antigen and pain surrogacy analysis in metastatic hormone-refractory prostate cancer.
-
Prostatic malignancy.
-
Pseudoanaplastic giant cell tumor of bone.
-
Quotient imaging with N-13 L-glutamate in osteogenic sarcoma: correlation with tumor viability.
-
Ra-223 Treatment for Bone Metastases in Castrate-Resistant Prostate Cancer: Practical Management Issues for Patient Selection.
-
Race does not predict skeletal-related events and all-cause mortality in men with castration-resistant prostate cancer.
-
Race does not predict the development of metastases in men with nonmetastatic castration-resistant prostate cancer.
-
Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.
-
Radiation therapy in the management of neuroblastoma: the Duke University Medical Center experience 1967-1984.
-
Radical surgery versus radiation therapy in early prostatic carcinoma.
-
Radiofrequency Ablation for the Palliative Treatment of Bone Metastases: Outcomes from the Multicenter OsteoCool Tumor Ablation Post-Market Study (OPuS One Study) in 100 Patients.
-
Radioisotope bone scanning characteristics of metastatic skeletal deposits of prostatic adenocarcinoma.
-
Radiologic demonstration of temporal development of bizarre parosteal osteochondromatous proliferation.
-
Radiosurgical treatment for Ewing's sarcoma of the lumbar spine: case report.
-
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma.
-
Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance).
-
Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer.
-
Rapid detection of bone metastasis at thoracoabdominal CT: accuracy and efficiency of a new visualization algorithm.
-
Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.
-
Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPC.
-
Real-world patient characteristics associated with survival of 2 years or more after radium-223 treatment for metastatic castration-resistant prostate cancer (EPIX study).
-
Receptor tyrosine kinase inhibitors for the treatment of osteosarcoma and Ewing sarcoma.
-
Registration of three-dimensional magnetic resonance and radionuclide skeletal images.
-
Regression of extrafoveal choroidal osteoma following photodynamic therapy.
-
Regression of metastatic breast cancer in a patient treated with the anti-angiogenic drug TNP-470.
-
Reply to F. Valcamonico et al.
-
Reply to Second malignancies in Ewing sarcoma survivors.
-
Response rate as an endpoint in clinical trials.
-
Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer.
-
Retinoblastoma metastatic to bone marrow. A case with florid spread.
-
Rheumatologic manifestations of cancer.
-
S-values for radium-223 and absorbed doses estimates for 223RACL2 using three computational phantoms.
-
STING suppresses bone cancer pain via immune and neuronal modulation.
-
Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world population.
-
Sarcoma of bone and soft tissue following treatment of Hodgkin's disease.
-
Sarcoma treatment in the era of molecular medicine.
-
Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis.
-
Sarcomas arising in Paget disease of bone: a clinicopathologic analysis of 70 cases.
-
Secondary reconstruction after vascularized fibular transfer.
-
Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy.
-
Skeletal Metastasis Evaluation: Value and Impact of PET/Computed Tomography on Diagnosis, Management and Prognosis.
-
Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acid.
-
Skeletal disorders in malignant disease.
-
Skeletal metastases of melanoma.
-
Solitary osteochondroma of the clavicle.
-
Solitary renal cell carcinoma metastasis to the hand: the need for wide excision or amputation.
-
Staging and Surveillance of Myxoid Liposarcoma: Follow-up Assessment and the Metastatic Pattern of 169 Patients Suggests Inadequacy of Current Practice Standards.
-
Staging non-small cell lung cancer with whole-body PET.
-
Staging techniques for lung cancer.
-
Stapled peptides as scaffolds for developing radiotracers for intracellular targets: Preliminary evaluation of a radioiodinated MDM2-binding stapled peptide in the SJSA-1 osteosarcoma model.
-
Sternal metastasis as first presentation of a well-differentiated papillary thyroid carcinoma.
-
Stress fractures of the proximal tibia in runners.
-
Synergistic activity of PARP inhibition by talazoparib (BMN 673) with temozolomide in pediatric cancer models in the pediatric preclinical testing program.
-
Systemic doxorubicin and intraarterial cisplatin preoperative chemotherapy plus postoperative adjuvant chemotherapy in patients with osteosarcoma.
-
TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis.
-
TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome.
-
Tenascin-C expression and distribution in cultured human chondrocytes and chondrosarcoma cells.
-
The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer.
-
The Role of Reconstructive Surgery After Skeletal and Soft Tissue Sarcoma Resection.
-
The clinical management of chondrosarcoma.
-
The clinical significance of tenascin-C splice variant expression in chondrosarcoma.
-
The combined use of the Ilizarov method and microsurgical techniques for limb salvage.
-
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance).
-
The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen.
-
The evolution and understanding of skeletal complication endpoints in clinical trials of tumors with metastasis to the bone.
-
The fibula-flexor hallucis longus osteomuscular flap.
-
The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma.
-
The nucleolar localization domain of the catalytic subunit of human telomerase.
-
The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress.
-
The role of Denosumab in joint preservation for patients with giant cell tumour of bone.
-
The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer.
-
The use of an expandable cage for corpectomy reconstruction of vertebral body tumors through a posterior extracavitary approach: a multicenter consecutive case series of prospectively followed patients.
-
The value of radionuclide bone imaging in selected patients with osteogenic sarcoma metastatic to lung.
-
Toward a drug development path that targets metastatic progression in osteosarcoma.
-
Traumatic pseudoaneurysm of the brachial artery caused by an osteochondroma, mimicking biceps rupture in a weightlifter: a case report.
-
Treatment and outcome of 82 patients with angiosarcoma.
-
Treatment of osseous metastases in patients with renal cell carcinoma.
-
Treatment of pathologic fracture of the humerus.
-
Treatment options for patients with prostate cancer who develop metastatic disease after hormonal therapy.
-
Treatment recommendations for primary extradural meningiomas.
-
Two HLA Class II Gene Variants Are Independently Associated with Pediatric Osteosarcoma Risk.
-
Unique and overlapping GLI1 and GLI2 transcriptional targets in neoplastic chondrocytes.
-
Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases.
-
Upper extremity compartmental anatomy: clinical relevance to radiologists.
-
Urinary cyclic adenosine monophosphate as an aid in the diagnosis of hyperparathyroidism.
-
Utility of fine-needle aspiration in the diagnosis of primary osteosarcoma.
-
Validation of a bone scan positivity risk table in non-metastatic castration-resistant prostate cancer.
-
Validation of the Brazilian version of the musculoskeletal tumor society rating scale for lower extremity bone sarcoma.
-
Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
-
Vascularized fibula-based physis transfer for pediatric proximal humerus reconstruction.
-
Venous thoracic outlet syndrome secondary to first rib osteochondroma in a pediatric patient.
-
YJ5 as an immunohistochemical marker of osteogenic lineage.
-
Keywords of People
-
-
Charles, Hal Cecil,
Adjunct Associate Professor in the Department of Radiology,
Radiology
-
Erickson, Harold Paul,
Professor Emeritus of Cell Biology,
Cell Biology
-
Hilton, Matthew James,
Associate Professor in Orthopaedic Surgery,
Cell Biology
-
Sullivan, Daniel Carl,
Professor Emeritus of Radiology,
Radiology